Carvykti Injection, Suspension
Product Images NDC 57894-111

4 FDA label images from Janssen Biotech, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carvykti (NDC 57894-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Carvykti 01)

Figure 1 (Carvykti 01)
Label for CARVYKTI (ciltacabtagene autoleucel) suspension for intravenous infusion by Janssen Biotech, Inc. The label specifies one sterile bag for infusion containing CAR-positive viable T cells in a frozen suspension with 5% DMSO. It includes storage and usage instructions, warnings, and patient match information. Barcodes and manufacturer details are shown, along with placeholders for lot number, expiration date, patient ID, and medical record information.*
FDA Label Image

Figure 2 (Carvykti 02)

Figure 2 (Carvykti 02)
Label for CARVYKTI (ciltacabtagene autoleucel) Injection, Suspension for Intravenous Infusion by Janssen Biotech, Inc. It lists a dosage form as one sterile bag for infusion with genetic modification and storage instructions, along with barcodes, lot, and expiration placeholders. The label includes handling warnings and manufacturer details.*
FDA Label Image

Carvykti-001-70ml (Carvykti 03)

Carvykti-001-70ml (Carvykti 03)
Label for CARVYKTI (ciltacabtagene autoleucel) injection, suspension for intravenous infusion. It is a cellular therapy supplied as one sterile bag for infusion, containing a patient-specific frozen suspension of CAR-positive viable T cells. The label includes storage instructions, usage warnings, and manufacturer information for Janssen Biotech, Inc. and Legend Biotech.*
FDA Label Image

Carvykti-002-30ml (Carvykti 04)

Carvykti-002-30ml (Carvykti 04)
The label is for CARVYKTI (ciltacabtagene autoleucel) injection suspension for intravenous infusion by Janssen Biotech, Inc. It includes dosing and storage instructions, emphasizing a single sterile bag for infusion stored in vapor phase liquid nitrogen at -120°C. It is for autologous intravenous use only, with no preservatives. The label shows manufacturing, marketing information, lot, expiration, patient details, and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.